- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Blue chip stocks
Global Pharmaceuticals & Biotech Blue chip stocks
Results
31
0 new
31 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$130.12 | -0.8% | -5.2% | US$20.7b | US$149.23 | PS4.7x | E75.6% | n/a | ||
RVTY | US$126.06 | 2.6% | 13.9% | US$15.6b | US$133.87 | PE78.8x | E25.8% | 0.2% | ||
GALD | CHF 80.00 | -1.5% | n/a | CHF 20.1b | CHF 82.43 | PS5.6x | E44.2% | n/a | ||
UCB | €161.35 | -0.8% | 108.1% | €30.6b | €165.00 | PE127.5x | E35.6% | 0.8% | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
BGNE | US$218.42 | 8.1% | 21.4% | US$22.6b | US$274.14 | PS7.5x | E64.1% | n/a | ||
NTRA | US$125.72 | -1.6% | 184.1% | US$15.3b | US$130.17 | PS11.4x | E70.5% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
EXAS | US$65.96 | -5.9% | -3.3% | US$12.6b | US$77.57 | PS4.7x | E70.9% | n/a | ||
VRTX | US$462.88 | -0.4% | 33.1% | US$119.5b | US$509.82 | PS11.6x | E46.4% | n/a | ||
ERF | €57.90 | 10.3% | 8.2% | €11.1b | €60.34 | PE34x | E18.4% | 0.9% | ||
QGEN | US$45.24 | 0.8% | 8.4% | US$10.0b | US$50.97 | PE138.3x | E37.1% | n/a | ||
A196170 | ₩341,000.00 | -6.1% | 400.7% | ₩18.1t | ₩271,666.67 | PS199.5x | E99.5% | n/a | ||
CSL | AU$285.10 | -2.9% | 13.7% | AU$141.0b | AU$312.28 | PE35.9x | E13.0% | 1.3% | ||
ARGX | €478.70 | -0.7% | 3.9% | €28.6b | €510.75 | PS19.3x | E58.4% | n/a | ||
VTRS | US$11.55 | 1.4% | 17.1% | US$13.9b | US$12.90 | PB0.7x | E14.4% | 4.2% | ||
4523 | JP¥5,525.00 | -4.0% | -33.5% | JP¥1.6t | JP¥7,459.19 | PE47.9x | E16.2% | 2.9% | ||
GILD | US$83.61 | -0.4% | 11.6% | US$103.4b | US$83.54 | PE98.8x | E36.0% | 3.7% | ||
GSK | UK£15.37 | 0.07% | 3.0% | UK£62.7b | UK£19.70 | PE15.5x | E14.3% | 3.8% | ||
INCY | US$65.83 | 0.1% | 14.0% | US$12.5b | US$74.17 | PE130.3x | E41.1% | n/a | ||
BMRN | US$70.58 | -0.2% | -20.2% | US$13.4b | US$104.74 | PE52.4x | E30.0% | n/a | ||
MEDP | US$331.44 | -9.4% | 36.9% | US$10.1b | US$389.47 | PE30.2x | E13.5% | n/a | ||
AZN | UK£116.54 | -1.1% | 5.0% | UK£180.7b | UK£138.09 | PE37.5x | E16.4% | 1.9% | ||
4502 | JP¥4,163.00 | -2.6% | -10.3% | JP¥6.7t | JP¥4,768.83 | PE44x | E22.4% | 4.7% |